No image published for this recall

No image published for this recall

Pms-busulfan 6 mg ml; out of specification (impurities)

Official notice

2 Sept 2025

Last checked

2 Sept 2025

Low riskHealth Canada

An official Health Canada notice concerns Pms-busulfan 6 mg ml; out of specification (impurities). The content of one of the impurities is out of specification in the affected lot. Published 2025-09-02.

What to do now

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

Recall number

78021

Official notice

2025-09-02

The hazard

The content of one of the impurities is out of specification in the affected lot.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Recall Numbers

78021

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Brand - Pharmascience Inc., Product Name - PMS-Busulfan 6 mg/mL, Market Authorization - DIN 02477343, Dosage Form - Solution, Strength - Busulfan 6 mg/mL, Lot number - 649247

Risk / hazard

The content of one of the impurities is out of specification in the affected lot.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Pharmascience, Pms-busulfan 6 MG Ml.

Source & status

Source

Health Canada

Tier

official

Category

HEALTH

Classification

Type III

App estimate

low

Recall details

Recall number

78021

Classification

Type III

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

CA
No image published for this recall

Pms-fluconazole 50 mg tablets; incorrect quantity of tablets

Low riskHealth Canada8 Jun 2026
CA
No image published for this recall

Pms-quetiapine: out of specification

Low riskHealth Canada20 Nov 2025
CA
No image published for this recall

Pms-sumatriptan: may not contain the correct amount of tablets (empty blister packs)

Medium riskHealth Canada29 Aug 2025
CA
No image published for this recall

Pms-methylphenidate cr 10 mg capsule; exceed the acceptable intake limit for n-nitroso-methylphenidate

High riskHealth Canada4 Jul 2025
CA
No image published for this recall

Pms-busulfan 6mg ml: impurity could be out of specification

Low riskHealth Canada29 Apr 2026
CA
No image published for this recall

Apo-fluoxetine: the impurities are out of specification and out of trend

Low riskHealth Canada10 Apr 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 2 Sept 2025. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.